Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Influence of obesity on localized prostate cancer patients treated with radical prostatectomy.

Qu YY, Dai B, Kong YY, Chang K, Ye DW, Yao XD, Zhang SL, Zhang HL, Yang WY.

Asian J Androl. 2013 Nov;15(6):747-52. doi: 10.1038/aja.2013.104. Epub 2013 Sep 16.

2.

[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].

Qu YY, Dai B, Chang K, Kong YY, Gu CY, Zhang GM, Wan FN, Wang HK, Zhang HL, Zhu Y, Ye DW.

Zhonghua Wai Ke Za Zhi. 2013 Dec;51(12):1089-93. Chinese.

PMID:
24499718
3.

Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.

Salonia A, Gallina A, Briganti A, Zanni G, Suardi N, Capitanio U, Colombo R, Bertini R, Freschi M, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2011 Apr;107(8):1243-9. doi: 10.1111/j.1464-410X.2010.09582.x. Epub 2010 Sep 30.

4.

Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy.

Salonia A, Gallina A, Briganti A, Abdollah F, Suardi N, Capitanio U, Colombo R, Freschi M, Rigatti P, Montorsi F.

Cancer. 2011 Sep 1;117(17):3953-62. doi: 10.1002/cncr.25985. Epub 2011 Mar 1.

5.

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.

Briganti A, Karakiewicz PI, Chun FK, Suardi N, Gallina A, Abdollah F, Freschi M, Doglioni C, Rigatti P, Montorsi F.

Int J Urol. 2009 Aug;16(8):676-81. doi: 10.1111/j.1442-2042.2009.02330.x. Epub 2009 Jul 8.

6.

Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?

Lee SE, Lee WK, Jeong MS, Abdullajanov M, Kim DS, Park HZ, Jeong SJ, Yoon CY, Byun SS, Choe G, Hong SK.

BJU Int. 2011 Apr;107(8):1250-5. doi: 10.1111/j.1464-410X.2010.09592.x. Epub 2010 Sep 29.

7.

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.

Dai B, Qu Y, Kong Y, Ye D, Yao X, Zhang S, Wang C, Zhang H, Yang W.

BJU Int. 2012 Dec;110(11 Pt B):E667-72. doi: 10.1111/j.1464-410X.2012.11465.x. Epub 2012 Sep 14.

8.

Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.

Jeong IG, Lim JH, You D, Kim MH, Choi HJ, Kim JK, Cho KS, Hong JH, Ahn H, Kim CS.

J Urol. 2013 Dec;190(6):2054-60. doi: 10.1016/j.juro.2013.06.035. Epub 2013 Jun 19.

PMID:
23791890
9.

Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?

Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, Catalona WJ.

J Urol. 2007 Jan;177(1):102-6; discussion 106.

PMID:
17162013
10.

A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schnall M, Tomaszewski J, Schultz D, Kao G, VanArsdalen K, Wein A.

Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):293-302.

PMID:
7928457
11.

Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.

Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB.

Urology. 2013 May;81(5):992-6. doi: 10.1016/j.urology.2012.10.080. Epub 2013 Feb 28.

PMID:
23453649
12.

Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.

Sankin A, Tareen B, Lepor H.

Prostate Cancer Prostatic Dis. 2009;12(2):204-8. doi: 10.1038/pcan.2009.2. Epub 2009 Feb 24.

PMID:
19238170
13.

[Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy].

Balssa L, Pastori J, Lillaz J, Panouillères M, Guichard G, Bernardini S, Chabannes E, Bittard H, Thiery-Vuillemin A, Kleinclauss F.

Prog Urol. 2015 Jun;25(7):420-7. doi: 10.1016/j.purol.2015.03.004. Epub 2015 Apr 16. French.

PMID:
25891781
14.

Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy.

Mucksavage P, Mitchell C, Kutikov A, Wein AJ, Torigian D, Malkowicz SB.

Urol Oncol. 2012 Sep;30(5):590-5. doi: 10.1016/j.urolonc.2010.07.007. Epub 2011 Mar 10.

PMID:
21396843
15.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

16.

Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy.

Narita S, Mitsuzuka K, Yoneyama T, Tsuchiya N, Koie T, Kakoi N, Kawamura S, Kaiho Y, Ohyama C, Tochigi T, Yamaguchi T, Habuchi T, Arai Y.

Prostate Cancer Prostatic Dis. 2013 Sep;16(3):271-6. doi: 10.1038/pcan.2013.16. Epub 2013 Jun 11.

PMID:
23752230
17.

Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer.

Gacci M, Corona G, Apolone G, Lanciotti M, Tosi N, Giancane S, Masieri L, Serni S, Maggi M, Carini M.

Prostate Cancer Prostatic Dis. 2010 Jun;13(2):168-72. doi: 10.1038/pcan.2010.4. Epub 2010 Mar 9. Erratum in: Prostate Cancer Prostatic Dis. 2010 Jun;13(2):202. Apolone, A [corrected to Apolone, G].

18.

Combining prostrate-specific antigen and Gleason score increases the diagnostic power of endorectal coil magnetic resonance imaging in prostate cancer pathological stage.

Tsao CW, Lin MH, Wu ST, Meng E, Tang SH, Chen HI, Sun GH, Yu DS, Chang SY, Cha TL.

J Chin Med Assoc. 2013 Jan;76(1):20-4. doi: 10.1016/j.jcma.2012.09.005. Epub 2012 Nov 23.

19.

Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy.

Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, Friedrichs PA, Moul JW.

Urology. 2001 Nov;58(5):723-8.

PMID:
11711349
20.

The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml.

Masieri L, Minervini A, Vittori G, Lanciotti M, Lanzi F, Lapini A, Carini M, Serni S.

Int Urol Nephrol. 2012 Aug;44(4):1031-8.

PMID:
22315156

Supplemental Content

Support Center